New data suggest that single-nucleotide polymorphisms (SNPs) that reduce the expression of CTLA4 are associated with minimal change disease (MCD) in children. Ohl and colleagues report that the frequencies of two such SNPs at the CTLA4 locus are increased in 96 children with biopsy-proven MCD (aged 10.7 ± 4.5 years) compared to 455 healthy adult controls. They hypothesize that the SNPs that decrease CTLA4 expression might be independent risk factors for the development of MCD.
References
Ohl, K. et al. CTLA4 polymorphisms in minimal change nephrotic syndrome in children: a case-control study. Am. J. Kidney Dis. 10.1053/j.ajkd.2014.01.427
Rights and permissions
About this article
Cite this article
CTLA4 polymorphisms in minimal change disease. Nat Rev Nephrol 10, 299 (2014). https://doi.org/10.1038/nrneph.2014.71
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2014.71